Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Cash and Short-Term Investments

Arena Pharmaceutical Cash and Short-Term Investments Chart (ARNA)

Arena Pharmaceutical annual/quarterly Cash and Short-Term Investments from 2000 to 2018.
  • Arena Pharmaceutical Cash and Short-Term Investments for the quarter ending December 12, 2018 was $161m a -220.51% decrease of -355m year over year
  • Arena Pharmaceutical Cash and Short-Term Investments for the last 12 months ending December 12, 2018 was $161m a -220.51% decrease of -355m year over year
  • Arena Pharmaceutical Annual Cash and Short-Term Investments for 2018 was $161m a -53.43% decrease of -86m from 2017
  • Arena Pharmaceutical Annual Cash and Short-Term Investments for 2017 was $247m a 63.29% increase of 156m from 2016
  • Arena Pharmaceutical Annual Cash and Short-Term Investments for 2016 was $91m a -72.18% decrease of -65m from 2015
Other Balance Sheet Metrics:
  • Arena Pharmaceutical Total Assets for the quarter ending September 09, 2018 was $610m a 44.38% increase of 271m year over year
  • Arena Pharmaceutical Other Liabilities for the quarter ending September 09, 2018 was $1m a -69.22% decrease of -1m year over year
  • Arena Pharmaceutical Total Equity for the quarter ending September 09, 2018 was $531m a 61.01% increase of 324m year over year
View Chart On Koyfin

Quarterly ARNA Cash and Short-Term Investments Data

12/2018$161m
09/2018$509m
06/2018$501m
03/2018$516m
12/2017$247m
09/2017$279m
06/2017$131m
03/2017$80m
12/2016$91m
09/2016$102m

Annual ARNA Cash and Short-Term Investments Data

2018$161m
2017$247m
2016$91m
2015$156m
2014$163m
2013$222m
2012$156m
2011$58m
2010$151m
2009$115m